TMCnet News
Vaccinex, Inc. to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference on March 19, 2019ROCHESTER, N.Y., March 13, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s disease, today announced that it will be presenting at Oppenheimer & Co.’s 29th Annual Healthcare Conference on Tuesday, March 19th at 3:55PM ET in Track 2. Maurice Zauderer, Ph.D., president & CEO, will be presenting an update on the Company’s ongoing clinical development programs and will be available for meetings with investors. The Oppenheimer & Co. 29th Annua Healthcare Conference will be held March 19-20, 2019 at the Westin New York Grand Central in New York City. Please contact conference organizers for investor meetings. About Vaccinex, Inc. Investor Contact Jeremy Feffer Media Contact Jules Abraham |